<DOC>
	<DOCNO>NCT02229903</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy Deep TMS ( DTMS ) treatment subject OCD . The device technology base application deep brain TMS mean repetitive pulse train predetermine frequency . The Brainsway DTMS study randomize , 10 week , double blind , multi-center trial compare active DTMS treatment sham treatment .</brief_summary>
	<brief_title>An Evaluation Safety Efficacy dTMS Treatment OCD</brief_title>
	<detailed_description>The OCD study compare one group OCD subject receive DTMS treatment ( HAC-coil ) second group OCD subject receive sham treatment ( sham coil ) . The treatment group receive 5 week daily DTMS treatment follow 4 treatment week 6 , total 29 treatment session . The control group receive treatment sham coil . Subjects may continue take SSRI medication ( prescribe ) antidepressant medication taper prior first treatment . SSRI medication approve OCD include Fluoxetine ( Prozac , Sarafem , Symbyax ) , Fluvoxamine ( Luvox , Luvox CR ) , Paroxetine ( Paxil , Paxil CR , Pexeva ) Sertraline ( Zoloft ) . Efficacy assess use Yale-Brown Obsessive Compulsive Scale score ( YBOCS ) , well efficacy scale . Safety assess monitor adverse event , vital sign , physical neurological examination use certain safety questionnaire .</detailed_description>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<criteria>• Outpatients Men woman 2268 year age . Subjects diagnose suffer OCD accord DSMIVTR . Subjects least moderate OCD , rating YBOCS score &gt; 20 . Subjects maintain SSRI medication least therapeutic dosage least 2 month prior study entry duration trial and/or subject maintain psychotherapeutic behavioral intervention therapy ( subject undergo CBT treatment must maintenance stage ( i.e. , assessment skill acquisition training stage ) . Subjects negative response Transcranial Magnetic Stimulation Safety Screening questionnaire ( TASS ) . According treat physician subject compliant take medication , applicable . Subject capable willing provide inform consent . Subject able adhere treatment schedule . • Subjects diagnose accord SCID I suffer Axis I diagnosis primary diagnosis . Subjects diagnose accord SCID II suffer severe Personality Disorder ( exclude Obsessive Compulsive Personality Disorder ) hospitalize due exacerbation relate borderline personality disorder . Present suicidal risk assess investigator use Scale Suicide Ideation ( SSI ) , brief mental status exam psychiatric interview significant suicide risk base HDRS21 item 3 score 3 4 history attempt suicide past year . Subject history epilepsy seizure ( EXCEPT therapeutically induce ECT ) history first degree relative . Subject increase risk seizure reason , include prior diagnosis increase intracranial pressure , history significant head trauma loss consciousness great equal 5 minute . Subject history head injury necessitate cranial surgery prolong coma . Subject history metal head include eye ear ( outside mouth ) . Subject known history metallic particle eye , implanted cardiac pacemaker intracardiac line , implanted neurostimulators , intracranial implant ( e.g. , aneurysm clip , shunt , stimulators , cochlear implant , electrode ) implant medical pump . Subject history significant hearing loss . Subjects significant neurological disorder insult include , limited : Any condition likely associate increase intracranial pressure Subject history substance abuse include alcoholism within past 6 month ( except nicotine caffeine ) . Inadequate communication patient . Subject currently participate another clinical study enrol another clinical study within 30 day prior study . Subjects suffer unstable physical , systemic metabolic disorder unstabilized blood pressure acute , unstable cardiac disease . Subject currently antidepressant medication SSRIs . Subject currently Clomipramine Subject previous treatment TMS Women breastfeed Women pregnant suspect pregnancy Women childbearing potential use medically accept form contraception engage sexual intercourse .</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>68 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>OCD</keyword>
</DOC>